Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 909 results for "glaxo"

GlaxoSmithKline PLC (LON:GSK) Hold Rating Reiterated by Deutsche Bank; The Target Price is Set to GBX 1540.00
Octafinance

Capstone Asset Management Co. Cuts Stake in GlaxoSmithKline pl...

Capstone Asset Management Co. cut its position in GlaxoSmithKline plc (NYSE:GSK) by 3.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 90,578 shares of ... Mideast Time, 15 hours ago
[x]  

206 images for glaxo

American Banking News - Stock Ratings, 1 day ago
Bidness Etc, 23 hours ago
Sify, 18 hours ago
Bidness Etc, 2 days ago
DirectorsTalk, 3 days ago
FOXNews.com, 18 hours ago
Reuters, 18 hours ago
Business Insider, 19 hours ago
Yahoo! Finance UK and Ireland, 22 hours ago
Investor's Business Daily, 1 day ago

Board and Committee changes

GlaxoSmithKline plc (the "Company") The Company announces that Dr Vivienne Cox, CBE, has been appointed to the Board of the Company as a Non-Executive Director with effect from 1 July 2016. She has been appointed a member of the Corporate ...
 London Stock Exchange20 hours ago BRIEF-GlaxoSmithKline appoints Vivienne Cox to board  Reuters UK21 hours ago Director Declaration  London Stock Exchange20 hours ago Board and Committee changes - GSK  Bloomberg20 hours ago
[x]  
Bidness Etc

GlaxoSmithKline Decides Against Initiating Phase 3 Trial of IONIS-TTRrx

Despite the recent rejection from GSK to initiate CARDIO-TTR, Ionis still remains positive on the success of its ongoing IONIS-TTRrx program GlaxoSmithKline plc (ADR) ( NYSE:GSK ) has decided against initiating a Phase-3 clinical trial, named ...
 Bidness Etc23 hours ago Fate of Ionis drug in doubt after GSK decides against Phase 3 study  BioPharma Dive19 hours ago Glaxo declines to proceed with late-stage study of Ionis Pharma's IONIS-TTRrx; Ionis down 7% premarket  Seeking Alpha1 day ago GSK Opts Against Phase III Study ...  Genetic Engineering News1 day ago
[x]  
Proactive Investors.co.uk

Glaxo's gene therapy for rare immune deficiency disorder approved in Europe

The European Commission approves Strimvelis, an ex-vivo stem cell gene therapy for the treatment of an ultra-rare inherited disorder called Severe Combined Immunodeficiency due to Adenosine Deaminase deficiency ( ADA-SCID ). Children born with the ...
 Seeking Alpha14 hours ago GlaxoSmithKline : Says European Commission Approves Stem-Cell Therapy  4 Traders20 hours ago GlaxoSmithKline PLC Strimvelis receives EC marketing authorisation  ADVFN UK21 hours ago GlaxoSmithKline PLC Board and Committee changes  ADVFN UK21 hours ago
[x]  
Yahoo! Finance UK and Ireland

There has never been a better time to buy GlaxoSmithKline plc, Persimmon plc and Admiral Group plc

If you are investing in shares, what do you look for? Well, I would say a key component is growth: increasing revenues and increasing earnings. And I would expect that a substantial proportion of those earnings to be paid out as dividends, leading ...
 Motley Fool UK23 hours ago Time to buy GlaxoSmithKline plc and Carillion plc?  Yahoo! Finance UK and Ireland1 week ago
[x]  
Motley Fool

BMO Downgrades Ionis Pharma After Platelet Concerns Spill Over To Volanesorsen

Shares of Ionis Pharmaceuticals Inc (NASDAQ: IONS ) lost 39.42 percent on Thursday after the company announced that GlaxoSmithKline plc (ADR) (NYSE: GSK ), which has the option to license the company's IONIS-TTRx — currently undergoing a Phase 3 ...
 Benzinga.com16 hours ago Why Ionis Pharmaceuticals Plummeted Today  FOXBusiness.com1 day ago
Nasdaq

Ionis Down, Glaxo Dumps IONIS-TTRRx Phase III Study Plans

Ionis Pharmaceuticals, Inc.'s IONS shares touched a 52-week low of $21.09 on May 26 after the company announced that its partner GlaxoSmithKline plc GSK has decided against starting a phase III outcome study CARDIO-TTR that was planned to evaluate ...
 Yahoo! Finance20 hours ago
[x]  
Yahoo! Finance UK and Ireland

Lloyds Banking Group plc vs GlaxoSmithKline plc: which is the better growth stock?

Today I am considering which is the better FTSE 100 (INDEXFTSE: UKX) growth candidate: banking star Lloyds (LSE: LLOY) or pharma giant GlaxoSmithKline (LSE: GSK) ? Slow and steady wins the race? For those seeking reliable earnings expansion in ...
 Motley Fool UK22 hours ago
[x]  
Sify

The GlaxoSmithKline building in Hounslow, west London

 Yahoo! Canada19 hours ago GSK gets EU approval for first gene therapy for children  London South East20 hours ago GSK gets EU approval for first...  DailyNews724.com5 hours ago Ionis shares plummet as GSK scraps heart drug trial plans  Pharma Letter18 hours ago
[x]  

GLAXOSMITHKLINE : Glaxo's Strimvelix Gene Therapy Gets European Marketing Authorisation

LONDON (Alliance News) - GlaxoSmithKline PLC, along with Fondazione Telethon and Ospedale San Raffaele, said Friday that gene therapy Strimvelis has been granted marketing authorisation in the European Union for the treatment of rare disease ...
 4 Traders21 hours ago GlaxoSmithKline Reports Long-Term Data For Gene Therapy In ADA-SCID  London South East3 days ago Glaxo's Strimvelix Gene Therapy Gets European Marketing Authorisation  London Stock Exchange21 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less